---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-087888"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:23:00.165560+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics stockholders elect directors, approve option exchange, ratify KPMG at 2025 annual meeting

## Summary
- Jennifer Buell and Ulf Wiinberg elected as Class I directors with 2,337,073 and 2,312,077 votes For, respectively.
- Option exchange proposal approved: 2,269,364 For, 97,538 Against, 1,317 Abstain, 424,803 broker non-votes.
- Ratification of KPMG LLP as auditor for FY2025: 2,773,188 For, 12,846 Against, 6,988 Abstain.

## SEC filing metadata
- accession: 0000950170-25-087888
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/0000950170-25-087888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/inkt-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-087888
- JSON: https://secwatch.observer/filing/0000950170-25-087888.json
- Plain text: https://secwatch.observer/filing/0000950170-25-087888.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.